logoTry Persana

Cofactor Genomics - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Cofactor Genomics including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Cofactor Genomics company logo

Cofactor Genomics is a leader in precision medicine through RNA decoding, working to bridge the gap in precision medicine and assist in diagnostics.

HeadquartersSan Francisco, United States
Team size11-50
Founded2008

What is Cofactor Genomics? - Company Overview & Details

Cofactor Genomics is Cofactor Genomics is a leader in precision medicine through RNA decoding, working to bridge the gap in precision medicine and assist in diagnostics. Founded in 2008, the company is headquartered in San Francisco, United States.

Who Founded Cofactor Genomics?

Cofactor Genomics was founded by Jarret Glasscock, Co-founders from Human Genome Project.

Who are the Key Executives at Cofactor Genomics? - Leadership Team

Cofactor Genomics is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Cofactor Genomics

Chris ParkerCEO

Chief Technology Officer (CTO) of Cofactor Genomics

Jarret GlasscockCTO

About Chris Parker - CEO of Cofactor Genomics

Chris Parker serves as the Chief Executive Officer of Cofactor Genomics, leading the company's strategic vision and operations.

Cofactor Genomics Company Details & Key Information

Where is Cofactor Genomics located?

Cofactor Genomics is headquartered in San Francisco, United States.

How many employees does Cofactor Genomics have?

Cofactor Genomics has 11-50 employees.

When was Cofactor Genomics founded?

Cofactor Genomics was founded in 2008.

Cofactor Genomics Official Website

How much funding has Cofactor Genomics raised?

Cofactor Genomics has raised $18 Million across 1 funding rounds. The most recent funding was completed on 2017-09-18.

Funding Overview

Cofactor Genomics has secured $18 million in Series A financing to advance its RNA-based diagnostic platform.

$18 Million
Total Funding Raised
1
Funding Rounds
2017-09-18
Latest Round

Cofactor Genomics Funding History

Series A
2017-09-18
$18 Million

Who are the key investors in Cofactor Genomics?

Cofactor Genomics is backed by 1 key investors including Menlo Ventures. These investors focus on Biotechnology, Healthcare, Data Science sectors.

Cofactor Genomics Investor Overview

1
Key Investors
3
Focus Areas
1
Notable Investments

Complete List of Cofactor Genomics Investors

Menlo Ventures

Menlo Ventures is a venture capital firm that supports innovative technology companies.

Investment Focus
Biotechnology
Healthcare
Data Science
Notable Portfolio Companies
Cofactor Genomics

What sectors do Cofactor Genomics investors focus on?

The investors backing Cofactor Genomics primarily focus on Biotechnology, Healthcare, Data Science sectors.

Biotechnology
Healthcare
Data Science

Featured Investor: Menlo Ventures

Menlo Ventures

Menlo Ventures is a venture capital firm that supports innovative technology companies.

Notable Investments: Cofactor Genomics

What are Cofactor Genomics's future plans?

Cofactor Genomics Focus on expanding the clinical evidence base for OncoPrism and increasing commercialization efforts.

Cofactor Genomics Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Cofactor Genomics face?

Cofactor Genomics has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Cofactor Genomics

1

Competition in the biotechnology sector

2

Regulatory hurdles

What opportunities does Cofactor Genomics have?

Cofactor Genomics has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Cofactor Genomics

1

Growth in oncology diagnostics

2

Partnerships with healthcare systems

Cofactor Genomics Strategic Position Summary

Key Focus Areas

Cofactor Genomics is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Cofactor Genomics?

Cofactor Genomics has 2 recent news updates covering key business developments and market activities.

Cofactor Genomics News Overview

2
Recent Articles
Active
Media Coverage
2025-01-09
Latest Update

What is Cofactor Genomics in the news for?

Cofactor Genomics is currently featured in news for Cofactor Genomics hires Chris Parker as CEO and Board Member. and other significant business developments.

Recent News Articles About Cofactor Genomics

Article 1
2025-01-09

Cofactor Genomics hires Chris Parker as CEO and Board Member.

Cofactor Genomics announces CEO change to drive company growth and OncoPrism expansion.

thehcdata.com
Read News
Article 2
2025-05-30

Cofactor Genomics attends event 30th Annual Meeting.

Cofactor presents breakthrough work combining RNA and AI for precision medicine at RNA Society's meeting.

biospace.com
Read News

Cofactor Genomics FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Cofactor Genomics including information about founders, CEO, funding history, investors, headquarters location, and company details. 19 frequently asked questions covering key information about the company.

Cofactor Genomics Questions & Answers - Company Information

Q1

What is Cofactor Genomics?

Cofactor Genomics is a leader in precision medicine through RNA decoding, working to bridge the gap in precision medicine and assist in diagnostics.

Q2

Who founded Cofactor Genomics?

Cofactor Genomics was founded by Jarret Glasscock, Co-founders from Human Genome Project.

Q3

Who is the CEO of Cofactor Genomics?

The CEO of Cofactor Genomics is Chris Parker.

Q4

How much funding has Cofactor Genomics raised?

Cofactor Genomics has raised a total of $$18 Million across 1 funding rounds. The most recent funding was completed on 2017-09-18.

Q5

Who are the investors in Cofactor Genomics?

Cofactor Genomics's key investors include Menlo Ventures.

Q6

Where is Cofactor Genomics headquartered?

Cofactor Genomics is headquartered in San Francisco, United States.

Q7

When was Cofactor Genomics founded?

Cofactor Genomics was founded in 2008.

Q8

How many employees does Cofactor Genomics have?

Cofactor Genomics has 11-50 employees.

Q9

What is Cofactor Genomics's official website?

You can visit Cofactor Genomics's official website at https://cofactorgenomics.com.

Q10

What was Cofactor Genomics's latest funding round?

Cofactor Genomics's latest funding round was a Series A round of $$18 Million completed on 2017-09-18.

Q11

Who is founder?

Jarret Glasscock

Q12

Who is cto?

Jarret Glasscock

Q13

What does the company do?

Cofactor Genomics focuses on using RNA decoding for precision medicine and developing diagnostic tools.

Q14

How much funding?

$18 Million

Q15

Latest funding date?

2017-09-18

Q16

Who are the investors?

Menlo Ventures Data Collective Ascension Ventures

Q17

What are the challenges?

Competition in the biotechnology sector Regulatory hurdles

Q18

What are the opportunities?

Growth in oncology diagnostics Partnerships with healthcare systems

Q19

Latest news?

Cofactor Genomics announces CEO change to drive company growth and OncoPrism expansion. Cofactor presents breakthrough work combining RNA and AI for precision medicine at RNA Society's meeting.

More Information About Cofactor Genomics

For additional details about Cofactor Genomics, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.